Abstract
Four types of hypersensitivities may be distinguished. Type I, or immediate hypersensitivity, occurs within about 30 min, is IgE antibody-mediated, and the allergic signs and symptoms are triggered by cross-linking of mast cell-bound IgE which leads to mast cell degranulation and release of inflammatory mediators. Drugs well known to cause type I reactions include β-lactams, neuromuscular blockers, and some NSAIDs. Anaphylactoid reactions may mimic the signs and symptoms of anaphylaxis but, unlike the latter reactions, anaphylactoid reactions are not immune-mediated. Clinical manifestations of anaphylaxis include erythema, urticaria, angioedema, bronchospasm, and cardiovascular collapse. Urticaria is often associated with angioedema and anaphylaxis. ACE inhibitors are responsible for one in six hospital admissions for angioedema. Types II and III hypersensitivities are known as antibody-dependent cytotoxic and immune complex-mediated hypersensitivities, respectively. Examples of drug-induced type II reactions are hemolytic anemia, thrombocytopenia, and granulocytopenia. A serum sickness-like reaction is the prototype type III drug hypersensitivity. Type IV drug hypersensitivities are mediated by antigen-specific T cells. Reactions occur 48–72 h after antigen exposure and are therefore referred to as delayed. Examples of delayed cutaneous reactions include allergic contact dermatitis, psoriasis, FDE, AGEP, DRESS, SJS, and TEN.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–7.
Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program. 2004;63–79.
Bock G, Goode J, editors. Anaphylaxis. Novartis foundation symposium 257. Chichester: Wiley; 2004.
Castells MC, editor. Anaphylaxis and hypersensitivity reactions. New York, NY: Humana; 2011.
Grattan CE, Charlesworth EN. Urticaria. In: Holgate ST, Church M, Lichtenstein LM, editors. Allergy. 3rd ed. Philadelphia, PA: Mosby; 2006. p. 95–106.
Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39–49.
Johansen JD, Frosch PJ, Lepoittevin J-P, editors. Contact dermatitis. Heidelberg: Springer; 2011.
Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter. Part I. Acute urticaria/angioedema. Part II. Chronic urticaria/angioedema. Ann Allergy Asthma Immunol. 2000;85:521–44.
Lieberman P. Definition and criteria for the diagnoses of anaphylaxis. In: Castells MC, editor. Anaphylaxis and hypersensitivity reactions. New York, NY: Humana; 2011. p. 1–12.
Litt JZ. Drug eruption reference manual. 12th ed. London: Taylor and Francis; 2006.
Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35–44.
Radic M, Martinovic Kaliterna D, Radic J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med. 2012;70:12–7.
Salama A, Schutz B, Kiefel V, et al. Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol. 1989;72:127–32.
Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2005;115:584–91.
Schön MP, Boehncke W-H. Psoriasis. N Engl J Med. 2005;352:1899–912.
Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009;9:316–21.
Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among Herpes viruses and antiviral and antidrug immune responses. Allergol Int. 2006;55:1–8.
Sidoroff A, Halevy S, Bavinck JNB, et al. Acute generalized exanthematous pustulosis (AGEP) – a clinical reaction pattern. J Cutan Pathol. 2001;28:113–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Baldo, B.A., Pham, N.H. (2013). Classification and Descriptions of Allergic Reactions to Drugs. In: Drug Allergy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7261-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7261-2_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7260-5
Online ISBN: 978-1-4614-7261-2
eBook Packages: MedicineMedicine (R0)